Galmed Pharmaceuticals (GLMD) Capital Expenditures Growth (3y) (2016 - 2022)
Galmed Pharmaceuticals (GLMD) Capital Expenditures Growth (3y) (2016 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2022 |
63.03% |
| Mar 31, 2022 |
37.00% |
| Dec 31, 2021 |
36.93% |
| Sep 30, 2021 |
66.24% |
| Mar 31, 2021 |
0.00% |
| Dec 31, 2020 |
243.41% |
| Sep 30, 2020 |
-141.01% |
| Dec 31, 2019 |
-32.64% |
| Sep 30, 2019 |
-18.56% |
| Mar 31, 2019 |
20.63% |
| Sep 30, 2018 |
-105.41% |
| Mar 31, 2018 |
20.63% |
| Sep 30, 2017 |
26.32% |
| Jun 30, 2017 |
50.00% |
| Mar 31, 2017 |
0.00% |
| Jun 30, 2016 |
-146.62% |
| Mar 31, 2016 |
-16.96% |
